methylphenidate has been researched along with Phobic Disorders in 5 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although the FDA recommends imipramine hydrochloride (IMI) only for temporary relief of symptoms of enuresis nocturna (EN), the drug has been applied to a number of other pediatric situations, including the Hyperkinetic Syndrome (HS), childhood depression, somnambulism and pavor nocturnus, school phobia, petit mal epilepsy, allergies, autism, encorpresis and head-banging." | 3.65 | Imipramine and children: a review and some speculations about the mechanism of drug action. ( Gualtieri, CT, 1977) |
| "Methylphenidate was well tolerated with no significant side effects." | 1.42 | Extended-release Methylphenidate Treatment and Outcomes in Comorbid Social Anxiety Disorder and Attention-deficit/Hyperactivity Disorder: 2 Case Reports. ( Çelebi, F; Ertekin, E; Kahn, DA; Koyuncu, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golubchik, P | 1 |
| Sever, J | 1 |
| Weizman, A | 1 |
| Koyuncu, A | 1 |
| Çelebi, F | 1 |
| Ertekin, E | 1 |
| Kahn, DA | 1 |
| Carter, G | 1 |
| LING, TM | 1 |
| BUCKMAN, J | 1 |
| Gualtieri, CT | 1 |
5 other studies available for methylphenidate and Phobic Disorders
| Article | Year |
|---|---|
Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia.
Topics: Adolescent; Adolescent Behavior; Attention Deficit Disorder with Hyperactivity; Central Nervous Syst | 2014 |
Extended-release Methylphenidate Treatment and Outcomes in Comorbid Social Anxiety Disorder and Attention-deficit/Hyperactivity Disorder: 2 Case Reports.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Delayed-Act | 2015 |
Animal behavior case of the month. Hyperactivity.
Topics: Animals; Anti-Anxiety Agents; Behavior Therapy; Behavior, Animal; Clonazepam; Dogs; Male; Methylphen | 2011 |
THE TREATMENT OF ANXIETY WITH LYSERGIC ACID AND METHYL PHENIDATE.
Topics: Anxiety; Anxiety Disorders; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Methylphenidate; Neur | 1963 |
Imipramine and children: a review and some speculations about the mechanism of drug action.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Depression; Dopamine; Enuresis; Epilepsy, Absence; | 1977 |